EU Energy Efficiency Directive & Methodologies for Greener Pharmaceuticals

Synopsis

The EU Fit for 55 focuses on specific topics that need particular attention and a strong green transition to achieve climate neutrality.

Within the ETERNAL project we have a focus on the application of Energy Efficiency Directive to the Pharmaceutical sector

Article 3 of the revised EED directive (EU/2023/1791), published in September 2023, provides a stronger and wider legal basis for the application of the principle “Energy Efficiency First”

Article 3 sets an obligation for EU countries to ensure that energy efficiency solutions are considered in planning, policy and investment decisions in both the energy and non-energy sectors.

Article 3 requires EU countries to develop and ensure the application of cost-benefit assessment methodologies that include proper assessment of the wider benefits of energy efficiency solutions from the societal perspective

The ETERNAL project will present how existing methodologies can be applied to show cost-benefits and develop new methodologies to assist asset owners in the pharmaceutical sector achieve higher energy performance for the energy services that are needed for production

A focus on energy services approach can provide a production driven design for sustainability, with energy performance criteria for equipment selection